It is demonstrated that circGABRB2_006 drives malignant progression of PTC through the miR-296-5p/FGFR1 signaling axis, highlighting its potential as a biomarker and therapeutic target in PTC.
It is revealed that circARHGAP10 functions as a tumor suppressor in CRC via two independent regulatory branches downstream of the circARHGAP10/miR-29a-5p cascade, and this newly identified circRNA-centered regulatory network provides a promising novel therapeutic target for CRC intervention.
Li-Yuan Liu, Yong-Cun Jia, Dong-Jie Li et al.· Molecular and Cellular Bioch...· 0 citations
To define the functional role of hsa_circ_0054391 (circ54391) in CRC progression and to evaluate its potential as a serum biomarker. Circ54391 was identified from databases and its expression was validated in CRC tissues, cell lines, and serum from healthy controls (
n
= 34), colorectal polyp patients (
n
= 3...
Cheng-Ying Xiong, Zhi-Qiang He, Xiao-Xue Liu et al.· Scientific Reports· 0 citations
Findings unveil a dual-axis regulatory mechanism in SKCM pathogenesis and position circ17399 as a promising diagnostic biomarker and actionable therapeutic target for melanoma intervention.
Ronghua Yang, Xiaoxiang Wang, Jia-Nan Zhuo et al.· Journal of Translational Med...· 0 citations
The data suggest that circPRKCA may act as a scaffold for RNA-binding proteins (RBPs), potentially facilitating the recruitment of SRSF1 to HIF-1A mRNA, which appeared to correlate with increased HIF-1A stability, and reveal novel diagnostic biomarkers and therapeutic strategies for NSCLC.
Hai-Ting Chen, Xing-Xing Jin, Leilei Tao et al.· Experimental Cell Research· 0 citations
Circular RNAs (circRNAs) exhibit wide expression across human tissues and play pivotal roles in tumorigenesis and cancer progression. However, studies regarding the function and mechanism of circRNAs in lung adenocarcinoma (LUAD) are insufficient, it needs to be further explored. This investigation aimes to describe dy...
Peini Xue, Yong-Heng Gao, Tianhao Li et al.· Experimental Cell Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.